Adalimumab enhances health-related quality of life in patients with active ankylosing spondylitis - Results from the atlas trial

被引：0
|
作者：
van der Heijde, D.
Luo, M.
Matsumoto, A. K.
Mease, P. J.
Torre-Alonso, J.
Wordsworth, B. P.
Wong, R.
Davis, J.
机构：
[1] Univ Hosp Maastricht, Maastricht, Netherlands
[2] Abbott Labs, Abbott Pk, IL 60064 USA
[3] Ctr Rheumatol & Bone Res, Wheaton, MD USA
[4] Swedish Med Ctr, Seattle, WA USA
[5] Univ Oviedo Asturias, Oviedo, Spain
[6] Neufield Orthopaed Ctr, Oxford, England
[7] Abbott, Parsippany, NJ USA
[8] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
RHEUMATOLOGY | 2006年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I63 / I64
页数：2
相关论文
共 50 条
  • [21] The role of contextual factors on health-related quality of life in ankylosing spondylitis
    Boonen, Annelies R.
    Gordeev, Vladimir
    Schachna, Lionell
    Maksymowych, Walter
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S355 - S355
  • [22] Role of contextual factors in health-related quality of life in ankylosing spondylitis
    Gordeev, V. S.
    Maksymowych, W. P.
    Evers, S. M. A. A.
    Ament, A.
    Schachna, L.
    Boonen, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) : 108 - 112
  • [23] The effect of intravenous golimumab on health-related quality of life and work productivity in adult patients with active ankylosing spondylitis: results of the phase 3 GO-ALIVE trial
    John D. Reveille
    Mark C. Hwang
    Abhijeet Danve
    Shelly Kafka
    Steven Peterson
    Kim Hung Lo
    Lilianne Kim
    Elizabeth C. Hsia
    Eric K. H. Chan
    Atul Deodhar
    Clinical Rheumatology, 2021, 40 : 1331 - 1341
  • [24] The effect of intravenous golimumab on health-related quality of life and work productivity in adult patients with active ankylosing spondylitis: results of the phase 3 GO-ALIVE trial
    Reveille, John D.
    Hwang, Mark C.
    Danve, Abhijeet
    Kafka, Shelly
    Peterson, Steven
    Lo, Kim Hung
    Kim, Lilianne
    Hsia, Elizabeth C.
    Chan, Eric K. H.
    Deodhar, Atul
    CLINICAL RHEUMATOLOGY, 2021, 40 (04) : 1331 - 1341
  • [25] Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients with Ankylosing Spondylitis: 28-Week Results of the GO-ALIVE Trial
    Reveille, John D.
    Deodhar, Atul
    Ince, Akgun
    Chan, Eric K. H.
    Peterson, Steven
    Li, Nan
    Hsia, Elizabeth C.
    Kim, Lilianne
    Lo, Kim Hung
    Xu, Stephen
    Harrison, Diane D.
    Han, Chenglong
    VALUE IN HEALTH, 2020, 23 (10) : 1281 - 1285
  • [26] Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients
    Ahmet Ozgül
    Fatma Peker
    M. Ali Taskaynatan
    A. Kenan Tan
    Kemal Dinçer
    Tunc Alp Kalyon
    Clinical Rheumatology, 2006, 25 : 168 - 174
  • [27] Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients
    Özgül, A
    Peker, F
    Taskaynatan, MA
    Tan, AK
    Dinçer, K
    Kalyon, TA
    CLINICAL RHEUMATOLOGY, 2006, 25 (02) : 168 - 174
  • [28] Oral health-related quality of life is associated with disease specific parameters in patients with ankylosing spondylitis
    Schmalz, Gerhard
    Douglas, Donya
    Douglas, David
    Patschan, Susann
    Patschan, Daniel
    Mueller, Gerhard A.
    Haak, Rainer
    Schmickler, Jan
    Ziebolz, Dirk
    CLINICAL ORAL INVESTIGATIONS, 2018, 22 (08) : 2889 - 2896
  • [29] Long-term adalimumab treatment reduces signs and symptoms in ankylosing spondylitis (AS) patients - Results from the ATLAS trial
    Van der Heijde, D.
    Kivitz, A.
    Schiff, M.
    Sieper, J.
    Dijkmans, B.
    Braun, J.
    Dougados, M.
    Reveille, J.
    Wong, R.
    Kupper, H.
    Davis, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 86 - 87
  • [30] Oral health-related quality of life is associated with disease specific parameters in patients with ankylosing spondylitis
    Gerhard Schmalz
    Donya Douglas
    David Douglas
    Susann Patschan
    Daniel Patschan
    Gerhard A. Müller
    Rainer Haak
    Jan Schmickler
    Dirk Ziebolz
    Clinical Oral Investigations, 2018, 22 : 2889 - 2896
12345